Newbury Pharmaceuticals
1.09 SEK
+8.94 %
Less than 1K followers
NEWBRY
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+8.94 %
-5.65 %
-5.65 %
-8.05 %
-56.77 %
-67.12 %
-82.48 %
-
-91.39 %
Newbury Pharmaceuticals is a pharmaceutical company. The company develops a pipeline of in-house developed and licensed products with a focus on specialty drugs in areas such as oncology, rare diseases, and neurology. The company conducts its business within the Scandinavian market. Newbury Pharmaceuticals was founded in 2020 and has its headquarters in Lund.
Read moreMarket cap
32.98M SEK
Turnover
64.27K SEK
Revenue
31.58M
EBIT %
-69.57 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
15.4
2026
Interim report Q2'26
15.4
2026
Extraordinary general meeting '26
8.7
2026
Interim report Q3'26
All
Webcasts
Press releases
ShowingAll content types
Newbury Pharmaceuticals extends and increases loan agreement to SEK 30m, convenes EGM
Newbury Pharmaceuticals has entered into a new partnership for Prucalopride tablets
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools